NASDAQ : ISPC
iSpecimen Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 0.7923 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.00M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.10M |
| Enterprise Value | -2.08M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 2.52M |
| Shares Outstanding | 2.52M |
| Shares Change (YoY) | +1,153.73% |
| Shares Change (QoQ) | +308.49% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 2.56% |
| Float | 2.52M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.43 |
| Forward PS | n/a |
| PB Ratio | 0.72 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.82 |
| Quick Ratio | 0.81 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -30,883.58 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -968.47% |
| Return on Assets (ROA) | -87.69% |
| Return on Invested Capital (ROIC) | -407.82% |
| Return on Capital Employed (ROCE) | -491.60% |
| Weighted Average Cost of Capital (WACC) | 11.94% |
| Revenue Per Employee | $66,615 |
| Profits Per Employee | -$1.63M |
| Employee Count | 7 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.78 |
| 52-Week Price Change | -97.33% |
| 50-Day Moving Average | 1.21 |
| 200-Day Moving Average | 4.78 |
| Relative Strength Index (RSI) | 31.55 |
| Average Volume (20 Days) | 262,829 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 158,754 |
| Short Previous Month | 160,992 |
| Short % of Shares Out | 6.30% |
| Short % of Float | 6.30% |
| Short Ratio (days to cover) | 0.48 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 466,302 |
| Gross Profit | -504,830 |
| Operating Income | -9.42M |
| Pretax Income | -11.42M |
| Net Income | -11.42M |
| EBITDA | -9.28M |
| EBIT | -9.42M |
| Loss Per Share | -$21.95 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 4.41M |
| Total Debt | 240,903 |
| Net Cash | 4.17M |
| Net Cash Per Share | $1.66 |
| Equity (Book Value) | 1.74M |
| Book Value Per Share | 1.14 |
| Working Capital | -992,538 |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -7.00M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 134,556 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.00M |
| FCF Per Share | -$2.78 |
Margins
| Measure | Value |
|---|
| Gross Margin | -108.26% |
| Operating Margin | -2,020.04% |
| Pretax Margin | -2,449.04% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1,153.73% |
| Shareholder Yield | -1,153.73% |
| Earnings Yield | -2,636.81% |
| FCF Yield | -338.68% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 118.33% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 28, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -20.11 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |